WR Miller

604 total citations
19 papers, 474 citations indexed

About

WR Miller is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, WR Miller has authored 19 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in WR Miller's work include Estrogen and related hormone effects (10 papers), Breast Cancer Treatment Studies (4 papers) and Glycosylation and Glycoproteins Research (3 papers). WR Miller is often cited by papers focused on Estrogen and related hormone effects (10 papers), Breast Cancer Treatment Studies (4 papers) and Glycosylation and Glycoproteins Research (3 papers). WR Miller collaborates with scholars based in United Kingdom and United States. WR Miller's co-authors include J. Michael Dixon, RA Elton, C. McDonald, Peter Mullen, W. N. Scott, Timothy Clair, SP Langdon, J F Smyth, A. Jayne Crew and AL Tesdale and has published in prestigious journals such as The Lancet, Cancer Research and British Journal of Cancer.

In The Last Decade

WR Miller

18 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
WR Miller United Kingdom 11 195 167 138 89 80 19 474
Kristy Driver United Kingdom 12 286 1.5× 174 1.0× 170 1.2× 50 0.6× 131 1.6× 14 599
Silvia Böhm Italy 11 187 1.0× 341 2.0× 60 0.4× 218 2.4× 185 2.3× 24 679
J. Jacquemier France 8 118 0.6× 147 0.9× 239 1.7× 97 1.1× 175 2.2× 20 518
Pablo Serrano‐Fernández Poland 18 330 1.7× 203 1.2× 184 1.3× 190 2.1× 160 2.0× 45 781
S. Cowan United Kingdom 11 127 0.7× 115 0.7× 201 1.5× 25 0.3× 56 0.7× 22 483
A. Kominea Greece 11 267 1.4× 212 1.3× 204 1.5× 114 1.3× 122 1.5× 12 640
Christina Mørk Hansen Denmark 14 264 1.4× 192 1.1× 257 1.9× 434 4.9× 54 0.7× 20 686
Alicia Parkes United Kingdom 5 332 1.7× 312 1.9× 464 3.4× 56 0.6× 145 1.8× 10 641
Gianluigi Bresciani Italy 6 174 0.9× 322 1.9× 74 0.5× 73 0.8× 155 1.9× 9 534
Sabine Kajita Japan 12 172 0.9× 135 0.8× 55 0.4× 76 0.9× 64 0.8× 25 492

Countries citing papers authored by WR Miller

Since Specialization
Citations

This map shows the geographic impact of WR Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WR Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WR Miller more than expected).

Fields of papers citing papers by WR Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WR Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WR Miller. The network helps show where WR Miller may publish in the future.

Co-authorship network of co-authors of WR Miller

This figure shows the co-authorship network connecting the top 25 collaborators of WR Miller. A scholar is included among the top collaborators of WR Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WR Miller. WR Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liu, MC, J. Michael Dixon, Rebecca B. Riggins, et al.. (2011). S1-8: Molecular Signaling Distinguishes Early ER Positive Breast Cancer Recurrences Despite Adjuvant Tamoxifen.. Cancer Research. 71(24_Supplement). S1–8. 6 indexed citations
2.
Miller, WR. (2006). Evolution of aromatase inhibitors as an endocrine treatment for breast cancer. Breast Cancer Research. 8(S2).
3.
Miller, WR, et al.. (2003). The therapeutic potential of aromatase inhibitors. Expert Opinion on Investigational Drugs. 12(3). 337–351. 29 indexed citations
4.
Miller, WR, et al.. (2003). Safety issues surrounding the use of aromatase inhibitors in breast cancer. Expert Opinion on Drug Safety. 2(1). 73–86. 5 indexed citations
5.
Saunders, Philippa T. K., et al.. (2002). Expression of oestrogen receptor beta (ERb1) protein in human breast cancer biopsies. 8 indexed citations
6.
Dixon, J. Michael, C. McDonald, RA Elton, & WR Miller. (1999). Risk of breast cancer in women with palpable breast cysts: a prospective study. The Lancet. 353(9166). 1742–1745. 76 indexed citations
7.
Mullen, Peter, WR Miller, James Mackay, et al.. (1997). BRCA1 5382insC mutation in sporadic and familial breast and ovarian carcinoma in Scotland. British Journal of Cancer. 75(9). 1377–1380. 8 indexed citations
8.
Weatherill, J R, et al.. (1995). c-erbB-3 protein expression in ovarian tumours. British Journal of Cancer. 71(4). 758–762. 39 indexed citations
9.
Miller, WR, et al.. (1994). Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa. British Journal of Cancer. 69(4). 738–742. 77 indexed citations
10.
Langdon, SP, et al.. (1992). Growth control by epidermal growth factor and transforming growth factor-α in human lung squamous carcinoma cells. British Journal of Cancer. 66(2). 254–259. 23 indexed citations
11.
Langdon, SP, et al.. (1991). Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferon. British Journal of Cancer. 63(6). 909–915. 5 indexed citations
12.
13.
Walker, R. A., et al.. (1990). Is apocrine differentiation in breast carcinoma of prognostic significance?. British Journal of Cancer. 62(1). 113–117. 16 indexed citations
14.
Langdon, SP, Hawkins Ra, AL Tesdale, et al.. (1990). Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. British Journal of Cancer. 62(2). 213–216. 77 indexed citations
15.
Mullen, Peter & WR Miller. (1989). Variations associated with the DNA analysis of multiple fine needle aspirates obtained from breast cancer patients. British Journal of Cancer. 59(5). 688–691. 7 indexed citations
16.
Miller, WR, et al.. (1989). Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status. British Journal of Cancer. 60(6). 834–837. 34 indexed citations
17.
Miller, WR, et al.. (1987). Prostaglandins and prognosis in human breast cancer. British Journal of Cancer. 56(3). 367–370. 13 indexed citations
18.
Miller, WR. (1987). Tumor Markers and their Significance in the Management of Breast Cancer. Progress in Clinical and Biological Research. Journal of Clinical Pathology. 40(1). 122.1–122. 1 indexed citations
19.
Kulle, Thomas J., et al.. (1984). Sulfur Dioxide and Ammonium Sulfate Effects on Pulmonary Function and Bronchial Reactivity in Human Subjects. American Industrial Hygiene Association Journal. 45(3). 156–161. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristy Driver Breakdown of academic impact, for papers by Silvia Böhm Breakdown of academic impact, for papers by J. Jacquemier Breakdown of academic impact, for papers by Pablo Serrano‐Fernández Breakdown of academic impact, for papers by S. Cowan Breakdown of academic impact, for papers by A. Kominea Breakdown of academic impact, for papers by Christina Mørk Hansen Breakdown of academic impact, for papers by Alicia Parkes Breakdown of academic impact, for papers by Gianluigi Bresciani Breakdown of academic impact, for papers by Sabine Kajita
Rankless by CCL
2026